• The first rapid antigen influenza test to
achieve 510(k) clearance as a Class II assay
under the new FDA Reclassification
performance requirements. DIGIVAL
provides objective result interpretation.
• Used with either nasopharyngeal swab or
nasal swab samples.
• Results available in just 15 minutes.
• Simple, straightforward testing procedure.
• Provides accurate results and includes
internal controls.
• Suitable for a wide variety of healthcare
settings.